日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Kinomic profiling to predict sunitinib response of patients with metastasized clear cell Renal Cell Carcinoma.

利用激酶组学分析预测转移性透明细胞肾细胞癌患者对舒尼替尼的反应

Oosterwijk-Wakka Jeannette C, Houkes Liesbeth, van der Zanden Loes F M, Kiemeney Lambertus A L M, Junker Kerstin, Warren Anne Y, Eisen Tim, Jaehde Ulrich, Radu Marius T, Ruijtenbeek Rob, Oosterwijk Egbert

Differentiating Benign from Malignant Thyroid Tumors by Kinase Activity Profiling and Dabrafenib BRAF V600E Targeting.

通过激酶活性分析和达拉非尼BRAF V600E靶向治疗区分良性甲状腺肿瘤和恶性甲状腺肿瘤

Hilhorst Riet, van den Berg Adrienne, Boender Piet, van Wezel Tom, Kievits Tim, de Wijn Rik, Ruijtenbeek Rob, Corver Willem E, Morreau Hans

C-Terminal Tag Location Hampers in Vitro Profiling of OGT Peptide Substrates by mRNA Display

C端标签位置阻碍了通过mRNA展示技术对OGT肽底物进行体外分析。

Shi, Jie; Sharif, Suhela; Balsollier, Cyril; Ruijtenbeek, Rob; Pieters, Roland J; Jongkees, Seino A K

Blood-based kinase activity profiling: a potential predictor of response to immune checkpoint inhibition in metastatic cancer

基于血液的激酶活性谱分析:转移性癌症免疫检查点抑制剂疗效的潜在预测指标

Hurkmans, Daan P; Verdegaal, Els M E; Hogan, Sabrina A; de Wijn, Rik; Hovestad, Lies; van den Heuvel, Dianne M A; Ruijtenbeek, Rob; Welters, Marij J P; van Brakel, Mandy; Basak, Edwin A; Pinedo, Herbert M; Lamers, Cor H J; van de Werken, Harmen J G; Groten, John P; Debets, Reno; Levesque, Mitchell P; Dummer, Reinhard; Kapiteijn, Ellen; Mathijssen, Ron H J; Aerts, Joachim G J V; van der Burg, Sjoerd H

Crizotinib sensitizes the erlotinib resistant HCC827GR5 cell line by influencing lysosomal function

克唑替尼通过影响溶酶体功能,使对厄洛替尼耐药的HCC827GR5细胞系对厄洛替尼敏感。

Van Der Steen, Nele; Keller, Kaylee; Dekker, Henk; Porcelli, Letizia; Honeywell, Richard J; Van Meerloo, Johan; Musters, René J P; Kathmann, Ietje; Frampton, Adam E; Liu, Daniel S K; Ruijtenbeek, Rob; Rolfo, Christian; Pauwels, Patrick; Giovannetti, Elisa; Peters, Godefridus J

Inactive immune pathways in triple negative breast cancers that showed resistance to neoadjuvant chemotherapy as inferred from kinase activity profiles

根据激酶活性谱推断,三阴性乳腺癌中存在不活跃的免疫通路,这些肿瘤对新辅助化疗表现出耐药性。

Sawada, Takeshi; Hilhorst, Riet; Rangarajan, Savithri; Yoshida, Masayuki; Tanabe, Yuko; Tamura, Kenji; Kinoshita, Takayuki; Shimoyama, Tatsu; van Beuningen, Rinie; Ruijtenbeek, Rob; Tsuda, Hitoshi; Koizumi, Fumiaki

Inhibition of O-GlcNAc transferase (OGT) by peptidic hybrids

肽杂合物对 O-GlcNAc 转移酶 (OGT) 的抑制作用

Zhang, Hao; Tomašič, Tihomir; Shi, Jie; Weiss, Matjaž; Ruijtenbeek, Rob; Anderluh, Marko; Pieters, Roland J

Cetuximab Prevents Methotrexate-Induced Cytotoxicity in Vitro through Epidermal Growth Factor Dependent Regulation of Renal Drug Transporters

西妥昔单抗通过表皮生长因子依赖性调节肾脏药物转运蛋白,在体外预防甲氨蝶呤诱导的细胞毒性

Caetano-Pinto, Pedro; Jamalpoor, Amer; Ham, Janneke; Goumenou, Anastasia; Mommersteeg, Monique; Pijnenburg, Dirk; Ruijtenbeek, Rob; Sanchez-Romero, Natalia; van Zelst, Bertrand; Heil, Sandra G; Jansen, Jitske; Wilmer, Martijn J; van Herpen, Carla M L; Masereeuw, Rosalinde

Analysis of Jak2 catalytic function by peptide microarrays: the role of the JH2 domain and V617F mutation

利用肽微阵列分析Jak2催化功能:JH2结构域和V617F突变的作用

Sanz, Arturo; Ungureanu, Daniela; Pekkala, Tuija; Ruijtenbeek, Rob; Touw, Ivo P; Hilhorst, Riet; Silvennoinen, Olli